UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 322

Sortiert nach

History and Review of anti‐Calcitonin Gene‐Related Peptide (CGRP) Therapies: From Translational Research to Treatment

Headache, 2018-11, Vol.58 (S3), p.238-275

Tepper, Stewart J.

2018

Volltextzugriff (PDF)

Non-Invasive Vagus Nerve Stimulation for the ACute Treatment of Cluster Headache: Findings From the Randomized, Double-Blind, Sham-Controlled ACT1 Study

Headache, 2016-09, Vol.56 (8), p.1317-1332

2016

Volltextzugriff (PDF)

A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study)

Cephalalgia, 2018-05, Vol.38 (6), p.1038-1048

2018

Volltextzugriff (PDF)

Effects of acute and preventive therapies for episodic and chronic cluster headache: A scoping review of the literature

Headache, 2022-03, Vol.62 (3), p.329-362

2022

Volltextzugriff (PDF)

Patent Foramen Ovale and Migraine: Closing the Debate-A Review

Headache, 2016-03, Vol.56 (3), p.462-478

2016

Volltextzugriff (PDF)

The temporal trend of placebo response in migraine prevention from 1990 to 2021: a systematic literature review and meta-analysis with regression

Journal of headache and pain, 2023-05, Vol.24 (1), p.54-54, Article 54

2023

Volltextzugriff (PDF)

Phase 3 randomized, double-blind, sham-controlled Trial of e-TNS for the Acute treatment of Migraine (TEAM)

Scientific reports, 2022-03, Vol.12 (1), p.5110-5110, Article 5110

2022

Volltextzugriff (PDF)

Anti‐Calcitonin Gene‐Related Peptide (CGRP) Therapies: Update on a Previous Review After the American Headache Society 60th Scientific Meeting, San Francisco, June 2018

Headache, 2018-11, Vol.58 (S3), p.276-290

Tepper, Stewart J.

2018

Volltextzugriff (PDF)

Commentary on 2022 guidelines on clinical trial design in cluster headache and further suggestions

Journal of headache and pain, 2024-03, Vol.25 (1), p.32-32, Article 32

2024

Volltextzugriff (PDF)

Serotonin syndrome in the acute treatment landscape of migraine: the lasmiditan experience

Frontiers in neurology, 2023-10, Vol.14, p.1291102-1291102

2023

Volltextzugriff (PDF)

Neurostimulation for Primary Headache Disorders, Part 1: Pathophysiology and Anatomy, History of Neuromodulation in Headache Treatment, and Review of Peripheral Neuromodulation in Primary Headaches

Headache, 2011-09, Vol.51 (8), p.1254-1266

2011

Volltextzugriff (PDF)

CGRP and headache: a brief review

Neurological sciences, 2019-05, Vol.40 (Suppl 1), p.99-105

Tepper, Stewart J.

2019

Volltextzugriff (PDF)

Variability in recurrence rates with acute treatments for migraine: why recurrence is not an appropriate outcome measure

Journal of headache and pain, 2022-12, Vol.23 (1), p.148-148, Article 148

2022

Volltextzugriff (PDF)

Long-term effectiveness of eptinezumab in patients with migraine and prior preventive treatment failures: extension of a randomized controlled trial

Journal of headache and pain, 2023-11, Vol.24 (1), p.155-155, Article 155

2023

Volltextzugriff (PDF)

Impact of erenumab on acute medication usage and health care resource utilization among migraine patients: a US claims database study

Journal of headache and pain, 2021-04, Vol.22 (1), p.27-27, Article 27

2021

Volltextzugriff (PDF)

Electrical Stimulation of Sphenopalatine Ganglion for Acute Treatment of Cluster Headaches

Headache, 2010-07, Vol.50 (7), p.1164-1174

2010

Volltextzugriff (PDF)

Treatment patterns of patients with migraine eligible for anti-CGRP pathway monoclonal antibodies

Frontiers in neurology, 2024-08, Vol.15, p.1433423

2024

Volltextzugriff (PDF)

Eptinezumab Demonstrated Efficacy Regardless of Prior Preventive Migraine Treatment Failure Type: Post Hoc Analyses of the DELIVER Study

Neurology and therapy, 2024-04, Vol.13 (2), p.339-353

2024

Volltextzugriff (PDF)

Acute Treatment of Migraine

Neurologic clinics, 2019-11, Vol.37 (4), p.727-742

Tepper, Stewart J.

2019

Volltextzugriff (PDF)

Reduction in acute migraine-specific and non-specific medication use in patients treated with erenumab: post-hoc analyses of episodic and chronic migraine clinical trials

Journal of headache and pain, 2021-07, Vol.22 (1), p.81-81, Article 81

2021

Volltextzugriff (PDF)

Adding eptinezumab to brief patient education to treat chronic migraine and medication-overuse headache: Protocol for RESOLUTION-A phase 4, multinational, randomized, double-blind, placebo-controlled study

Frontiers in neurology, 2023-02, Vol.14, p.1114654-1114654

2023

Volltextzugriff (PDF)

Headache Currents Thanks You

Headache, 2020-11, Vol.60 (10), p.2653-2653

Tepper, Stewart J.

2020

Volltextzugriff (PDF)

A close association of freedom from pain, migraine-related functional disability, and other outcomes: results of a post hoc analysis of randomized lasmiditan studies SAMURAI and SPARTAN

Journal of headache and pain, 2021-12, Vol.22 (1), p.101-101, Article 101

2021

Volltextzugriff (PDF)

Multimodal Migraine Management and the Pursuit of Migraine Freedom: A Narrative Review

Neurology and therapy, 2023-10, Vol.12 (5), p.1533-1551

2023

Volltextzugriff (PDF)

A Brief Review of Gepants

Current pain and headache reports, 2023-09, Vol.27 (9), p.479-488

2023

Volltextzugriff (PDF)

1 – 25 von 322

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(307)
Mit Volltextzugriff
(289)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(206)
Life Sciences & Biomedicine
(203)
Humans
(183)
Neurosciences & Neurology
(182)
Clinical Neurology
(180)
Migraine
(140)
Migraine Disorders - Drug Therapy
(86)
Headache
(84)
Female
(80)
Adult
(72)
Neurology
(70)
Male
(67)
Middle Aged
(62)
Biological And Medical Sciences
(61)
Medical Sciences
(61)
Headaches
(52)
Patients
(48)
Vascular Diseases And Vascular Malformations Of The Nervous System
(45)
Treatment Outcome
(43)
Pharmacology. Drug Treatments
(39)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

History and Review of anti‐Calcitonin Gene‐Related Peptide (CGRP) Therapies: From Translational Research to Treatment

Non-Invasive Vagus Nerve Stimulation for the ACute Treatment of Cluster Headache: Findings From the Randomized, Double-Blind, Sham-Controlled ACT1 Study

A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study)

Effects of acute and preventive therapies for episodic and chronic cluster headache: A scoping review of the literature

Patent Foramen Ovale and Migraine: Closing the Debate-A Review

The temporal trend of placebo response in migraine prevention from 1990 to 2021: a systematic literature review and meta-analysis with regression

Phase 3 randomized, double-blind, sham-controlled Trial of e-TNS for the Acute treatment of Migraine (TEAM)

Anti‐Calcitonin Gene‐Related Peptide (CGRP) Therapies: Update on a Previous Review After the American Headache Society 60th Scientific Meeting, San Francisco, June 2018

Commentary on 2022 guidelines on clinical trial design in cluster headache and further suggestions

Serotonin syndrome in the acute treatment landscape of migraine: the lasmiditan experience

Neurostimulation for Primary Headache Disorders, Part 1: Pathophysiology and Anatomy, History of Neuromodulation in Headache Treatment, and Review of Peripheral Neuromodulation in Primary Headaches

CGRP and headache: a brief review

Variability in recurrence rates with acute treatments for migraine: why recurrence is not an appropriate outcome measure

Long-term effectiveness of eptinezumab in patients with migraine and prior preventive treatment failures: extension of a randomized controlled trial

Impact of erenumab on acute medication usage and health care resource utilization among migraine patients: a US claims database study

Electrical Stimulation of Sphenopalatine Ganglion for Acute Treatment of Cluster Headaches

Treatment patterns of patients with migraine eligible for anti-CGRP pathway monoclonal antibodies

Eptinezumab Demonstrated Efficacy Regardless of Prior Preventive Migraine Treatment Failure Type: Post Hoc Analyses of the DELIVER Study

Acute Treatment of Migraine

Reduction in acute migraine-specific and non-specific medication use in patients treated with erenumab: post-hoc analyses of episodic and chronic migraine clinical trials

Adding eptinezumab to brief patient education to treat chronic migraine and medication-overuse headache: Protocol for RESOLUTION-A phase 4, multinational, randomized, double-blind, placebo-controlled study

Headache Currents Thanks You

A close association of freedom from pain, migraine-related functional disability, and other outcomes: results of a post hoc analysis of randomized lasmiditan studies SAMURAI and SPARTAN

Multimodal Migraine Management and the Pursuit of Migraine Freedom: A Narrative Review

A Brief Review of Gepants

Suchergebnisse filtern